Immunologic and Molecular Pathways Modulated by Oral Isotretinoin: Evidence from Human Studies

Background: Oral isotretinoin is an established systemic treatment for moderate-to-severe acne vulgaris, with biological effects extending beyond sebaceous gland suppression to the regulation of inflammatory, immune, and molecular processes. However, human evidence regarding these effects remains fragmented across studies investigating different biomarkers and regulatory pathways. This systematic review aimed to synthesize the available human evidence on immunological and molecular changes associated with oral isotretinoin therapy. Methods: A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. PubMed, Scopus, and Web of Science were systematically searched for eligible human studies published in English. Results: Eleven studies collectively reporting 920 patients with acne vulgaris receiving oral isotretinoin and 279 healthy controls (1199 participants) met the eligibility criteria. The investigated outcomes encompassed hematological and systemic inflammatory indices, circulating cytokines and immune mediators, antimicrobial peptides, transcription factors, gene and protein expression, and transcriptomic alterations. Oral isotretinoin was associated with reductions in several systemic inflammatory indices, particularly NLR, SII, and SIRI, although findings for other hematological parameters were inconsistent. Treatment-associated changes were also observed in YKL-40, IL-8, IL-36, TWEAK, dermcidin, FoxO1, and p53/TP53, while transcriptomic analysis identified alterations in immune- and inflammation-related gene expression and pathways. Conclusions: Available human evidence indicates that oral isotretinoin is associated with changes in systemic inflammatory activity, circulating immune mediators, and selected molecular pathways. However, substantial heterogeneity across studies and the moderate-to-high risk of bias limit firm mechanistic conclusions.

Authors

Institutions

Publication Details

Journal
Cells
Published
2026-11-17
DOI
https://doi.org/10.3390/cells15222095
Primary Topic
Acne and Rosacea Treatments and Effects
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Immunologic and Molecular Pathways Modulated by Oral Isotretinoin: Evidence from Human Studies

Danuta Nowicka, Anastazja Andrusiewicz, Sofiia Khimuk, Katsiaryna Lipskaya
2 links
Cells
Acne and Rosacea Treatments and Effects
article

Immunologic and Molecular Pathways Modulated by Oral Isotretinoin: Evidence from Human Studies

Danuta Nowicka, Anastazja Andrusiewicz, Sofiia Khimuk, Katsiaryna Lipskaya
article en

Abstract

Background: Oral isotretinoin is an established systemic treatment for moderate-to-severe acne vulgaris, with biological effects extending beyond sebaceous gland suppression to the regulation of inflammatory, immune, and molecular processes. However, human evidence regarding these effects remains fragmented across studies investigating different biomarkers and regulatory pathways. This systematic review aimed to synthesize the available human evidence on immunological and molecular changes associated with oral isotretinoin therapy. Methods: A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines. PubMed, Scopus, and Web of Science were systematically searched for eligible human studies published in English. Results: Eleven studies collectively reporting 920 patients with acne vulgaris receiving oral isotretinoin and 279 healthy controls (1199 participants) met the eligibility criteria. The investigated outcomes encompassed hematological and systemic inflammatory indices, circulating cytokines and immune mediators, antimicrobial peptides, transcription factors, gene and protein expression, and transcriptomic alterations. Oral isotretinoin was associated with reductions in several systemic inflammatory indices, particularly NLR, SII, and SIRI, although findings for other hematological parameters were inconsistent. Treatment-associated changes were also observed in YKL-40, IL-8, IL-36, TWEAK, dermcidin, FoxO1, and p53/TP53, while transcriptomic analysis identified alterations in immune- and inflammation-related gene expression and pathways. Conclusions: Available human evidence indicates that oral isotretinoin is associated with changes in systemic inflammatory activity, circulating immune mediators, and selected molecular pathways. However, substantial heterogeneity across studies and the moderate-to-high risk of bias limit firm mechanistic conclusions.

CellsVol. 15(22)
Wroclaw Medical University (PL)
Good health and well-being
Acne and Rosacea Treatments and Effects
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon